Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

被引：0
|
作者：
Francisco Robert
Alan Sandler
Joan H. Schiller
Glenn Liu
Karen Harper
Lev Verkh
Xin Huang
Jennifer Ilagan
Lesley Tye
Richard Chao
Anne M. Traynor
机构：
[1] University of Alabama at Birmingham,
[2] Comprehensive Cancer Center,undefined
[3] Oregon Health & Science University,undefined
[4] University of Texas Southwestern,undefined
[5] Division of Hematology and Oncology,undefined
[6] University of Wisconsin Carbone Cancer Center,undefined
[7] Pfizer Inc,undefined
[8] Global Research and Development,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Sunitinib; Docetaxel; Solid tumors; Phase I; NSCLC; Antiangiogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：669 / 680
页数：11
相关论文
共 50 条
  • [41] Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies—results of a phase I dose-escalation study
    Normand Blais
    D. Ross Camidge
    Derek J. Jonker
    Denis Soulières
    Scott A. Laurie
    Sami G. Diab
    Ana Ruiz-Garcia
    Aron Thall
    Ke Zhang
    Richard C. Chao
    Laura Q. Chow
    Investigational New Drugs, 2013, 31 : 1487 - 1498
  • [42] A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
    de Braud, F.
    Cascinu, S.
    Spitaleri, G.
    Pilz, K.
    Clementi, L.
    Liu, D.
    Sikken, P.
    De Pas, T.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2341 - 2346
  • [43] Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors
    Doz, Francois
    Locatelli, Franco
    Baruchel, Andre
    Blin, Nicolas
    De Moerloose, Barbara
    Frappaz, Didier
    Dworzak, Michael
    Fischer, Matthias
    Stary, Jan
    Fuertig, Rene
    Riemann, Kathrin
    Taube, Tillmann
    Reinhardt, Dirk
    PEDIATRIC BLOOD & CANCER, 2019, 66 (10)
  • [44] Phase I dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumors
    Seto, Takashi
    Esaki, Taito
    Hirai, Fumihiko
    Arita, Shuji
    Nosaki, Kaname
    Makiyama, Akitaka
    Kometani, Takuro
    Fujimoto, Chinatsu
    Hamatake, Motoharu
    Takeoka, Hiroaki
    Agbo, Felix
    Shi, Xiaojin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Final results of a phase I dose-escalation study of ON 01910.Na in combination with oxaliplatin in patients with advanced solid tumors
    Ohnuma, T.
    Holland, J. F.
    Goel, S.
    Wilck, E.
    Lehrer, D.
    Ghalib, M. H.
    Chaudhary, I.
    Wilhelm, F.
    Swami, U.
    Mani, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] A phase I dose-escalation and pk study of continuous oral rucaparib in patients with advanced solid tumors
    Flynn, M.
    Shapiro, G.
    LoRusso, P.
    Kristeleit, R.
    Patel, M.
    Infante, J.
    Giordano, H.
    Borrow, J.
    Jaw-Tsai, S.
    Burris, H., III
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S185 - S185
  • [47] Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies-results of a phase I dose-escalation study
    Blais, Normand
    Camidge, D. Ross
    Jonker, Derek J.
    Soulieres, Denis
    Laurie, Scott A.
    Diab, Sami G.
    Ruiz-Garcia, Ana
    Thall, Aron
    Zhang, Ke
    Chao, Richard C.
    Chow, Laura Q.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1487 - 1498
  • [48] Phase I dose-escalation study of aflibercept plus docetaxel in nasopharyngeal carcinoma and other solid tumors
    Huang, Yan
    Zou, Ben-Yan
    Zhao, Li-Ping
    Zhao, Hong-Yun
    Zhao, Yuan-Yuan
    Xue, Cong
    Zhang, Jian-Wei
    Xu, Fei
    Chen, Li-Kun
    Liu, Jun-Ling
    Hu, Zhi-Huang
    Wu, Xuan
    Zhang, Jing
    Ma, Yu-Xiang
    Wei, Chen-Lu
    Ma, Ying
    Zhang, Li
    FUTURE ONCOLOGY, 2014, 10 (16) : 2579 - 2591
  • [49] A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors
    Amarantidis, K.
    Houhouli, K.
    Papatheodorou, K.
    Miloussis, A.
    Matthaios, D.
    Chatzaki, E.
    Lyrantzopoulos, N.
    Tsaroucha, A.
    Tentes, A.
    Kakolyris, S.
    ONCOLOGY RESEARCH, 2006, 16 (06) : 281 - 287
  • [50] Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies
    Bahleda, Rastislav
    Baker, Jackie
    Massard, Christophe
    Gadgeel, Sirish M.
    Rogers, Jane E.
    Izzedine, Hassan
    Deutsch, Eric
    Garris, Jeana L.
    Khan, Akbar
    Boelle, Emmanuelle
    Assadourian, Sylvie
    Soria, Jean-Charles
    Ajani, Jaffer A.
    ONCOLOGY, 2016, 90 (01) : 10 - 20
12345